Tiens Biotech (TBV) Chairman Offers to Take Co. Private at $1.72/Share
Tweet Send to a Friend
In an SEC filing on Tiens Biotech (AMEX: TBV), Chairman and CEO Jinyuan Li has offered to take the company private at $1.72 per share.
The exec currently owns more than 95 percent of the company's outstanding shares.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The exec currently owns more than 95 percent of the company's outstanding shares.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Viropharma, Inc. (VPHM) Said to Attract Acquisition Interest - Reuters
- Huawei Has 'No Plans to Acquire Nokia' (NOK) - Bloomberg
- Johnson Controls (JCI) Opens Bidding for Auto Electronics Unit to PE Firms
Create E-mail Alert Related Categories
Insider Trades, Mergers and Acquisitions, Private Equity
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
